Chunghwa Chemical Synthesis & Biotech Co., Ltd., based in New Taipei City, Taiwan, is a leading manufacturer and exporter specializing in the production of active pharmaceutical ingredients (APIs), excipients, and advanced biotechnological products. With decades of experience in chemical synthesis, biotech research, and the pharmaceutical industry, the company has built a solid reputation for its commitment to quality and innovation.
Core Business
Chunghwa Chemical Synthesis & Biotech Co., Ltd. primarily operates in the pharmaceutical manufacturing sector, offering an extensive range of APIs, excipients, and biotechnological products. The company specializes in the production of active ingredients used in pharmaceutical formulations, including those for cardiovascular diseases, oncology, immunology, endocrinology, and dermatology.
The company’s diverse portfolio extends to excipients that are essential in the pharmaceutical industry for the formulation and stabilization of drug products. Chunghwa's research and development (R&D) capabilities enable them to continue innovating and providing high-quality products to the pharmaceutical market.
Product and Service Offerings
Chunghwa Chemical Synthesis & Biotech Co., Ltd. offers a wide variety of products that cater to the pharmaceutical, biotech, and healthcare industries. Their product offerings include:
1. Active Pharmaceutical Ingredients (APIs)
- Anti-Anxiety Agents: Products developed to address anxiety-related disorders.
- Antidiabetics: Ingredients used in the formulation of drugs aimed at controlling blood sugar levels in diabetic patients.
- Laxatives: APIs designed for gastrointestinal treatments.
- Antifungals: Ingredients used in the treatment of fungal infections.
- Cardiovascular Drugs: Active ingredients aimed at managing heart disease and high blood pressure.
- Antineoplastic: Active ingredients for cancer treatments and therapies.
- Skeletal Muscle Relaxants: Drugs used for muscle relaxation and pain relief.
2. Excipients
- Decyl Oleate: Used in pharmaceutical formulations as a surfactant.
- DL-Glutamic Acid, DL-Valine: Excipients that enhance drug solubility and stability.
- Ethylenediamine Excipient: Commonly used in drug manufacturing to improve formulation.
- Glyceryl Monostearate: Emulsifier for pharmaceutical products.
- Isopropyl Myristate: Used to increase drug absorption and enhance the effectiveness of topical treatments.
- Polyethylene Glycol: A versatile excipient that enhances drug solubility and stability in many formulations.
3. Drugs in Development
- Cardiology/Vascular Diseases: Development of drugs targeting cardiovascular conditions and vascular health.
- Dermatology: Focus on skin care and dermatological diseases.
- Endocrinology: R&D in hormone-related therapies for metabolic and endocrine disorders.
- Hematology: Development of treatments for blood-related conditions.
- Oncology: Advanced research on cancer therapeutics.
- Nephrology: Development of drugs targeting kidney diseases.
4. Pharmaceutical R&D Services
- The company also provides services related to the development and synthesis of custom APIs for third-party pharmaceutical manufacturers, catering to specialized needs in various therapeutic areas such as oncology, immunology, and neurology.
Specialisation and Core USP
Chunghwa Chemical Synthesis & Biotech Co., Ltd. has carved out a niche in the pharmaceutical industry through its deep expertise in chemical synthesis and biotechnological research. The company’s key strengths include:
-
Diverse API Portfolio: With a wide range of APIs covering therapeutic areas like cardiology, oncology, dermatology, and infectious diseases, Chunghwa has established itself as a reliable supplier of high-quality pharmaceutical ingredients.
-
Research-Driven Approach: The company’s strong R&D division continues to push the boundaries of pharmaceutical science, developing new formulations and improving existing products.
-
Compliance and Quality Assurance: Chunghwa adheres to international standards of manufacturing practices, ensuring that its products meet the highest quality and safety standards.
Financials
Chunghwa Chemical Synthesis & Biotech Co., Ltd. is a privately held company, and while detailed financial data is not publicly available, its long-standing presence in the pharmaceutical sector and consistent export activity signal stable financial health. The company’s growth is supported by continuous innovation and a strong foothold in international markets.
Shipment Data
Chunghwa Chemical Synthesis & Biotech Co., Ltd. has a robust international distribution network, exporting products globally. The company is known for its timely delivery and efficient logistics, particularly to markets in North America, Europe, and Asia.
Over the years, Chunghwa has significantly expanded its export volume, catering to the pharmaceutical and biotech industries worldwide. The company's focus on quality assurance and manufacturing efficiency allows it to serve as a trusted partner for pharmaceutical companies globally.
Target Market
Chunghwa Chemical Synthesis & Biotech Co., Ltd. primarily caters to the pharmaceutical industry, with its target market spanning:
- Pharmaceutical Manufacturers: Supplying APIs and excipients to companies involved in drug formulation and production.
- Biotech Companies: Providing advanced biotech products for use in various therapeutic applications.
- Contract Research Organizations (CROs): Offering R&D services to support drug development processes.
- Healthcare Providers: Delivering active ingredients for the production of therapeutic treatments targeting various diseases and conditions.
Capabilities
Chunghwa Chemical Synthesis & Biotech Co., Ltd. stands out for its highly advanced chemical synthesis processes and deep expertise in biotechnology. The company’s capabilities include:
-
Chemical Synthesis Expertise: Their expertise in chemical synthesis enables the efficient production of high-quality APIs and excipients.
-
Custom Formulation Development: Chunghwa works closely with clients to develop tailor-made formulations for various pharmaceutical applications, ensuring product efficacy and compliance with regulatory standards.
-
Advanced R&D Facilities: The company invests heavily in research and development to keep pace with the latest trends and innovations in the pharmaceutical and biotech sectors.
-
Global Manufacturing Network: Chunghwa operates in full compliance with international manufacturing standards and has the infrastructure to support large-scale production for both local and international clients.
Certifications and Compliance
Chunghwa Chemical Synthesis & Biotech Co., Ltd. adheres to the highest standards in manufacturing, ensuring its products meet the necessary regulatory requirements for distribution in global markets. While specific certifications are not publicly listed, the company complies with international quality assurance standards, particularly in the areas of pharmaceutical and biotech product development.
Customer Testimonials
Chunghwa’s commitment to product quality and customer satisfaction has earned the trust of numerous pharmaceutical and biotech companies worldwide. A key customer testimonial includes:
"Chunghwa has been an integral partner in supplying high-quality APIs for our oncology drug line. Their reliability and product consistency have been key factors in the success of our formulations."
Major Achievements
-
Product Innovation: Chunghwa’s continued investment in R&D has led to the development of several successful APIs that address critical therapeutic needs in areas such as oncology, immunology, and cardiology.
-
Global Expansion: The company has successfully penetrated multiple international markets, ensuring a strong export business and global recognition for its pharmaceutical products.
-
Industry Leadership: Chunghwa is recognized as a leader in chemical synthesis and biotech research, providing high-quality APIs and excipients to major pharmaceutical companies around the world.
Chunghwa Chemical Synthesis & Biotech Co., Ltd. continues to innovate, improve, and lead in the pharmaceutical manufacturing sector, with a solid commitment to quality, sustainability, and customer satisfaction.